Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials

Massimo Gentile, Pellegrino Musto, Salvatore Palmieri et al.|Haematologica|2023

Cited by 19